Factors associated with tuberculosis treatment outcomes among tuberculosis patients attending tuberculosis treatment centres in 2016-2017 in Mogadishu, Somalia

Marian Khalif Ali, Simon Karanja, Mohammed Karama, Marian Khalif Ali, Simon Karanja, Mohammed Karama

Abstract

Introduction: World Health Organization (WHO) reported that tuberculosis (TB) was a major health problem and the second leading cause of mortality globally. An estimated 1.8 million TB deaths were reported in 2015. In Somalia, the average TB incidence was 274 cases per 100,000 people in 2014; prevalence was 513 per 100,000 population; and mortality rate excluding human immune deficiency virus (HIV)/TB co-infection was 64/100,000. In addition, the prevalence rates of multi-drug resistant (MDR)-TB are still high, 5.2% among new cases and 40.7% for retreatment cases. The objective of this study was to determine individual and institutional level factors associated with TB treatment outcomes (TB-TOs) among patients attending TBTCs in Mogadishu.

Methods: The study design was cross-sectional, using quantitative and qualitative methods. Data was collected using interviewer administered semi-structured questionnaires and key in-depth interviews in 2016/2017. Qualitative data was coded using NVIVO8 and quantitative data analyzed using descriptive and inferential statistics at 95% confidence interval using SPSS20 software.

Results: The study used a sample of 385 TB patients. There were 315(81.8%) successful TB-TOs. Individual level factors-marital status, education level, HIV status, treatment category and knowledge on TB influenced TB-TOs (p-value < 0.05). Being married, educated, HIV-negative, new treatment case and knowledgeable on TB increased odds of successful TB-TOs (OR > 0, p value < 0.05) compared to other patients. TBTCs factors did not influence TB-TOs (p-value > 0.05).

Conclusion: TB-TOs were mainly affected by patient individual factors. There was need for patient education on TB management and treatment; and improved patient-health provider relationship.

Keywords: Tuberculosis in Somalia; treatment centers; tuberculosis treatment outcomes.

References

    1. Ali SA, Mavundla TR, Fantu R, Awoke T. Outcomes of TB treatment in HIV co-infected TB patients in Ethiopia: a cross-sectional analytic study. BMC Infectious Diseases. 2016;16(1):640.
    1. Raviglione M, Sulis G. Tuberculosis 2015: burden, challenges and strategy for control and elimination. Infectious Disease Reports. 2016;8(2):6570.
    1. Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk factors for tuberculosis. Pulmonary medicine. 2013;2013:828939.
    1. Esmail H, Barry CE, Young DB, Wilkinson RJ. Philosophical Transactions of the Royal Society B: Biological Sciences. The ongoing challenge of latent tuberculosis. 2014;369(1645):20130437.
    1. World Health Organization . Global tuberculosis report 2013. Geneva: 2013.
    1. Qian H, Li Y, Nielsen PV, Hyldgård CE, Wong TW, Chwang ATY. Dispersion of exhaled droplet nuclei in a two-bed hospital ward with three different ventilation systems. Indoor air. 2006;16(2):111–128.
    1. Tschopp R, Schelling E, Hattendorf J, Aseffa A, Zinsstag J. Risk factors of bovine tuberculosis in cattle in rural livestock production systems of Ethiopia. Preventive veterinary medicine. 2009;89(3-4):205–211.
    1. Centers for Disease Control and Prevention Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force. Centers for Disease Control and Prevention. 2009;58(3):1–43.
    1. Sulis G, Centis R, Sotgiu G, D'Ambrosio L, Pontali E, Spanevello A, et al. Recent developments in the diagnosis and management of tuberculosis. NPJ Primary Care Respiratory Medicine. 2016;26:16078.
    1. Sia IG, Wieland ML. Current concepts in the management of tuberculosis. Elsevier. 2011;86(4):348–361.
    1. Rao J. QRS for BDS II Year. Elsevier Health Sciences; 2014.
    1. Jordan TS, Davies PD. Clinical tuberculosis and treatment outcomes. The International Journal of Tuberculosis and Lung Disease. 2010;14(6):683–688.
    1. Vesosky B, Turner J. The influence of age on immunity to infection with Mycobacterium tuberculosis. Immunological reviews. 2005;205:229–243.
    1. Mehta JB, Emery MW, Girish M, Ryland P, Jr, Roy TM. Atypical Pott's disease: localized infection of the thoracic spine due to Mycobacterium avium-intracellulare in a patient without human immunodeficiency virus infection. Southern medical journal. 2003;96(7):685–689.
    1. World Health Organization . Global tuberculosis control: WHO report 2011. Geneva: 2011.
    1. World Health Organization . Global tuberculosis report 2014. Geneva: 2014.
    1. World Health Organization . Global tuberculosis report. 2016.
    1. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The lancet. 2013;380(9859):2197–2223.
    1. World Health Organization . Global Tuberculosis Report 2015. Geneva: world Health Organization.; 2015.
    1. Dalbo M, Tamiso A. Incidence and Predictors of Tuberculosis among HIV/AIDS Infected Patients: a five-year retrospective follow-up study. Advances in Infectious Diseases. 2016;6(02):70–81.
    1. Galan A, Cucu A. Disability-adjusted life years as a key tool for the analysis of the burden of disease. Health: Systems-Lifestyle-Policies. 2013;142
    1. Ukwaja KN, Modebe O, Igwenyi C, Alobu I. The economic burden of tuberculosis care for patients and households in Africa: a systematic review. The International Journal of Tuberculosis and Lung Disease. 2012;16(6):733–739.
    1. Yarnell J, Mendis S, Connolly S, Sambo LG, Kebede D, Jakab Z, et al. Epidemiology and Disease Prevention: a global approach. Global health in the 21st century. 2013;369
    1. World Bank . World Development Indicators. 2014.
    1. World Health Organization . Global tuberculosis report. 2016.
    1. Inambao A, Adan A, Mohamed A. Report on the evaluation of the global fund TB program in Somalia. 2013.
    1. Sindani I. Multidrug-Resistant Tuberculosis, Somalia, 2010-2011. Emerging Infectious Disease journal-CDC. 2013;19(3):478–480.
    1. Korenromp EL, Williams BG, Gouws E, Dye C, Snow RW. Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. The Lancet infectious diseases. 2003;3(6):349–358.
    1. Zager EM, McNerney R. Multidrug-resistant tuberculosis. BMC Infectious Diseases. 2008;8:10.
    1. Barlett JE, Kotrlik JW, Higgins CC. Organizational research: determining appropriate sample size in survey research. Information technology, learning and performance journal. 2001;19(1):43–50.
    1. Gebrezgabiher G, Romha G, Ejeta E, Asebe G, Zemene E, Ameni G. Treatment Outcome of Tuberculosis Patients under Directly Observed Treatment Short Course and Factors Affecting Outcome in Southern Ethiopia: a five-Year retrospective study. PloS one. 2016;11(2):e0150560.
    1. Berhe G, Enquselassie F, Aseffa A. Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region, Northern Ethiopia. BMC public health. 2012;12:537.
    1. Lange C, Abubakar I, Alffenaar JWC, Bothamley G, Caminero JA, Carvalho ACC, et al. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. European Respiratory Journal. 2014 Jul;44(1):23–63.
    1. Vasankari T, Holmström P, Ollgren J, Liippo K, Kokki M, Ruutu P. Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. BMC public health. 2007;7:291.
    1. Seddon JA, Hesseling AC, Willemse M, Donald PR, Schaaf HS. Culture-confirmed multidrug-resistant tuberculosis in children: clinical features, treatment and outcome. Clinical infectious diseases. 2012;54(2):157–166.
    1. Babatunde OA, Elegbede OE, Ayodele M, Fadare JO, Isinjaye AO, Ibirongbe DO, et al. Factors affecting treatment outcomes of tuberculosis in a tertiary health center in Southwestern Nigeria. Int Rev Soc Sci Hum. 2013;4(2):209–218.
    1. Sengul A, Akturk UA, Aydemir Y, Kaya N, Kocak ND, Tasolar FT. Factors affecting successful treatment outcomes in pulmonary tuberculosis: a single-center experience in Turkey, 2005-2011. he Journal of Infection in Developing Countries. 2015;9(08):821–828.
    1. Olukolade R, Hassan A, Ogbuji Q, Olujimi S, Okwuonye L, Kusimo O, et al. Role of treatment supporters beyond monitoring daily drug intake for TB-patients: findings from a qualitative study in Nigeria. Journal of Public Health. 2017 Apr;9(4):65–73.
    1. Muture BN, Keraka MN, Kimuu KP, Kabiru EW, Ombeka VO, et al. Factors associated with default from treatment among tuberculosis patients in nairobi province, Kenya: a case control study. BMC Public Health. 2011;11:696.
    1. Havlir DV, Getahun H, Sanne I, Nunn P. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. Jama. 2008;300(4):423–430.
    1. Widjanarko B, Gompelman M, Dijkers M, Van der Werf MJ. Factors that influence treatment adherence of tuberculosis patients living in Java, Indonesia. Patient Prefer Adherence. 2009;3:231–238.
    1. Liang L, Wu Q, Gao L, Hao Y, Liu C, Xie Y, et al. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China. horax. 2012;67(7):632–638.
    1. Mesfin MM, Newell JN, Madeley RJ, Mirzoev TN, Tareke IG, Kifle YT, et al. Cost implications of delays to tuberculosis diagnosis among pulmonary tuberculosis patients in Ethiopia. BMC Public Health. 2010;10:173.
    1. Chimbindi N, Bärnighausen T, Newell ML. Patient satisfaction with HIV and TB treatment in a public programme in rural KwaZulu-Natal: evidence from patient-exit interviews. BMC health services research. 2014 Jan;14:32.
    1. Karyadi E, West CE, Schultink W, Nelwan RH, Gross R, Amin Z, et al. A double-blind, placebo-controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinica lresponse and nutritional status. The American journal of clinical nutrition. 2002;75(4):720–727.
    1. World Health Organization . The Stop TB Strategy: building on and enhancing DOTS to meet the TB-related Millennium Development Goals. 2006.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren